SCHEMBL22949059

SCHEMBL22949059

Brc1ccc2c(c1)S(c1ccc3ccccc3c1)(c1ccc3ccccc3c1)c1cc(Br)ccc1-2

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 5/20 0.55
PTPRC P08575 1/20 0.35
ALDH1A1 P00352 2/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
KDM4E B2RXH2 1/20 0.34
MAPT P10636 1/20 0.34
CYP1A2 P05177 4/20 0.34
CYP2C19 P33261 1/20 0.34
HTT P42858 1/20 0.34
AHR P35869 1/20 0.33
DHODH Q02127 1/20 0.33
ACHE P22303 1/20 0.33
PTPN1 P18031 1/20 0.33
GSTP1 P09211 1/20 0.32
CYP3A4 P08684 1/20 0.32
HSD17B10 Q99714 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22947536 0.95 CYP2A6 (0.50) CYP2A6PTPRCALDH1A1MEN1KMT2A
SCHEMBL21123265 0.81 PTPRC (0.39) CYP2A6PTPRCALDH1A1MAPTCYP1A2
SCHEMBL11984775 0.76 PTPRC (0.40) CYP2A6PTPRCALDH1A1CYP1A2AHR
SCHEMBL22947450 0.74 CYP2A6 (0.39) CYP2A6PTPRCALDH1A1MEN1KMT2A
SCHEMBL154221 0.73 CYP2A6 (1.00) CYP2A6ALDH1A1MEN1KMT2AKDM4E
SCHEMBL29485684 0.73 CYP2A6 (1.00) CYP2A6ALDH1A1MEN1KMT2AKDM4E
SCHEMBL22947629 0.72 ALDH1A1 (0.39) PTPRCALDH1A1MEN1KMT2AKDM4E
SCHEMBL11984776 0.72 PTPRC (0.33) CYP2A6PTPRCAHR
SCHEMBL22947624 0.72 CYP2A6 (0.40) CYP2A6ALDH1A1MEN1KMT2AKDM4E
SCHEMBL22947360 0.72 CYP2A6 (0.35) CYP2A6PTPRCALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210036245-A1 HETEROAROMATIC COMPOUNDS MERCK PATENT GMBH (DE) 2021-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210036245-A1 HETEROAROMATIC COMPOUNDS ETV6, FES, LEF1 CYP2A6 1117/4885PTPRC 3228/4885ALDH1A1 752/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.